Gubra AS (CHIX:GUBRAC) Valuation Rank


CHIX:GUBRAC Gubra AS CHIX:GUBRAC
73 GF Score
Price kr354.50
GF Value kr3,083.18
! 3 Warning Signs
View Full Analysis

What is Gubra AS Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Gubra AS Valuation Rank Related Terms

CHIX:GUBRAC
73GF Score
Gubra AS CHIX:GUBRAC
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Gubra AS (CHIX:GUBRAC) Overvalued in 2026?

Based on GuruFocus' analysis, Gubra AS stock appears to be undervalued. The current stock price of kr354.50 is trading 88.5% below its estimated GF Value™ of kr3,083.18.

Key valuation signals for CHIX:GUBRAC:

  • Valuation Rank:
  • GF Value™: kr3,083.18 vs. price of kr354.50 (88.5% below fair value)
  • GF Score™: 73/100 with 3 warning signs

No single metric tells the full story. See the CHIX:GUBRAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gubra AS Business Description

Other Exchanges GUBRA:DenmarkPI3:Germany
Address Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
73GF Score

Get the complete analysis for CHIX:GUBRAC

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr354.50
Price
kr3,083.18
GF Value